Rescaling pain intensity measures for meta-analyses of analgesic medicines for low back pain appears justified: an empirical examination from randomised trials
Abstract Objective Meta-analyses of analgesic medicines for low back pain often rescale measures of pain intensity to use mean difference (MD) instead of standardised mean difference for pooled estimates. Although this improves clinical interpretability, it is not clear whether this method is justif...
Main Authors: | Michael A. Wewege, Matthew D. Jones, Sam A. Williams, Steven J. Kamper, James H. McAuley |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12874-022-01763-x |
Similar Items
-
Changes in pain and concurrent pain medication use following compounded topical analgesic treatment for chronic pain: 3- and 6-month follow-up results from the prospective, observational Optimizing Patient Experience and Response to Topical Analgesics study
by: Gudin JA, et al.
Published: (2017-10-01) -
Effects of osteopathic manipulative treatment associated with pain education and clinical hypnosis in individuals with chronic low back pain: study protocol for a randomized sham-controlled clinical trial
by: Guilherme Luis Santana Luchesi, et al.
Published: (2022-12-01) -
Back Pain Breakthrough /
by: Lynch, Robert Porter, author 186399
Published: (1997) -
The Effect of Metronidazole on Hemorrhoidectomy Pains
by: . P. Mirzabeygi, M.D, et al.
Published: (2007-01-01) -
Commentary: The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-analysis
by: Rodrigo R. N. Rizzo, et al.
Published: (2021-04-01)